ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The problem of cutoff levels in a screened population - Appropriateness of informing screenees about their risk of having prostate carcinoma

Horninger, W; Bartsch, G; Snow, PB; Brandt, JM; Partin, AW
Cancer2001-4-15DOI: 10.1002/1097-0142(20010415)91:8+<1667::AID-CNCR1181>3.0.CO;2-L
20被引2阅读
引用收藏
分享

摘要

BACKGROUND. Transrectal prostate biopsy decisions often have been based on absolute cutoff values for total and free prostate-specific antigen IPSA). The authors decided that it would be more appropriate to develop risk profiles for the individual patient to allow him to decide whether to undergo a prostate biopsy. METHODS, To develop risk profiles, the authors first used multivariate logistic regression analysis to analyze 2054 males who were part of the Tyrol (Austria) PSA Screening Project. Second, artificial neural network (ANN) analyses were performed using data from 3474 males who also were part of the Tyrol PSA Screening Project and who had undergone prostate biopsy. These analyses were compared with standard cutoff levels of specificity for the detection of prostate carcinoma. RESULTS. To the authors' knowledge, this was the first time that multivariate logistic regression analysis was used to decide whether to perform prostate biopsies based on risk profiles rather than on single cutoff levels. For the detection of prostate carcinoma, at sensitivity levels of 90-95%, the ANN was 150-200% more specific than the standard cutoff points, For screened volunteers with total PSA levels below 4 ng/mL, ANN showed a lower cancer predictive ability in comparison with volunteers with total PSA levels above 4 ng/mL. However, the ANN was approximately 150-200% more specific than the standard cutoff levels in both groups. CONCLUSIONS. At high sensitivity levels, ANN increased the specificity for prostate carcinoma detection in a PSA-based screened population. The improvement in specificity between standard cutoff levels and ANN ranged between 150-200% and was not affected by the presence of benign prostatic hyperplasia or prostatitis. Cancer 2001;91:1667-72.

学科与关键词

关键词
artificial neural networkprostate-specific antigen screeningprostate carcinomapreoperative staging
相关
加载中…
  • Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perceptron network
    Finne, P; Finne, R; Auvinen, A; Juusela, H; Aro, J; Mttnen, L; Hakama, M; Rannikko, S; Tammela, TLJ; Stenman, UHUrology, 2000, 56(3): 418-422.被引 121
  • The comparability of models for predicting the risk of a positive prostate biopsy with prostate-specific antigen alone:: A systematic review
    Schroder, Fritz; Kattan, Michael W.European Urology, 2008, 54(2): 274-290.被引 112
  • PSA and new biomarkers within multivariate models to improve early detection of prostate cancer
    Stephan, Carsten*; Cammann, Henning; Meyer, Hellmuth-A.; Lein, Michael; Jung, KlausCancer Letters, 2007, 249(1): 18-29.被引 52
查看全部 →

发表信息

论文状态
公开发表
期刊
Cancer
发表日期
2001-04-15
卷期
第 91 卷, 第 8 期
页码
1667-1672
DOI
10.1002/1097-0142(20010415)91:8+<1667::AID-CNCR1181>3.0.CO;2-L
语言
ENGLISH
成果收录
SCIE

作者

  • H

    Horninger, W (第一作者)

  • B

    Bartsch, G

查看全部 5 位作者收起作者
  • S

    Snow, PB

  • B

    Brandt, JM

  • P

    Partin, AW

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417